Technical analysis of LENSAR Inc (LNSR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Price Performance
| 1 month | -15.26% |
| 3 months | +20.91% |
| Year-to-date | -40.33% |
| 1 year | -45.22% |
| 3 years | +112.23% |
52-Week Range
| 52-week High | $12.94 |
| 52-week Low | $4.95 |
| Avg Volume (90d) | 103K |
Technical Indicators
| SMA 50 | $6.97 |
| SMA 200 | $8.25 |
| Beta | 0.98 |
| 30-day Volatility (annualised) | 94.8% |
| Price vs SMA 50 | -0.5% |
| Price vs SMA 200 | -15.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $12.30 | |
| 2025-11 | $10.18 | -17.2% |
| 2025-12 | $11.63 | +14.2% |
| 2026-01 | $12.73 | +9.5% |
| 2026-02 | $11.97 | -6.0% |
| 2026-03 | $5.96 | -50.2% |
| 2026-04 | $5.23 | -12.2% |
| 2026-05 | $5.80 | +10.9% |
| 2026-06 | $5.71 | -1.6% |
| 2026-07 | $5.01 | -12.3% |
| 2026-08 | $8.39 | +67.5% |
| 2026-09 | $6.94 | -17.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | $0.88 | $2.29B |
| 2026-09-15 | | |
| 2026-09-15 | | $69M |
| 2026-09-15 | $0.01 | $23M |
| 2026-09-15 | $0.02 | $114M |
Price
| Price | $7.09 |
| Market Cap | $87M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 5.44 |
| Price / Book | 5.70 |
| EV / EBITDA | 2.65 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.16 |
| Current Ratio | 2.39 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -2.84 |